Sequenom Downgraded by Piper Jaffray to Neutral (SQNM)
Sequenom (NYSE:SQNM) was downgraded by analysts at Piper Jaffray to a “neutral” rating in a research report issued to clients and investors on Friday, Analyst Ratings Network.com reports.
Sequenom (NYSE:SQNM) traded down 1.51% during mid-day trading on Friday, hitting $2.6001. 3,212,999 shares of the company’s stock traded hands. Sequenom has a one year low of $1.65 and a one year high of $4.90. The stock’s 50-day moving average is $2.38 and its 200-day moving average is $2.89. The company’s market cap is $300.9 million.
Sequenom, Inc (NYSE:SQNM) is a diagnostic testing and genetics analysis company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.